Quantcast
Home > Quotes > OXFD

Oxford Immunotec Global PLC Ordinary Shares (OXFD) Quote & Summary Data

OXFD 
$16.37
*  
0.50
2.96%
Get OXFD Alerts
*Delayed - data as of Feb. 22, 2019 15:49 ET  -  Find a broker to begin trading OXFD now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    OXFD After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 16.37 / $ 16.40
Today's High / Low
$ 16.94 / $ 16.26
Share Volume
84,258
50 Day Avg. Daily Volume
121,818
Previous Close
$ 16.87
52 Week High / Low
$ 19.1873 / $ 10.3601
Market Cap
431,535,038
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
84,258
50 Day Avg. Daily Volume:
121,818

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.45

Trading Range

The current last sale of $16.37 is 58.01% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 16.94 $ 19.1873
 Low: $ 16.26 $ 10.3601

Company Description (as filed with the SEC)

We are a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for underserved immune-regulated conditions. Our focus is on four areas: infectious diseases transplantation, autoimmune and inflammatory disease and immune-oncology. We believe these areas are particularly attractive because they involve large patient populations and chronic conditions that present the opportunity for both initial diagnosis and additional testing to monitor the conditions. These immune-regulated conditions also tend to be characterized by wide variation in presentation and progression and often require expensive therapies, making diagnostic tests that can better categorize patients and inform treatment pathways particularly useful and cost-effective. Lastly, we believe these conditions to be underserved as the industry lacks the appropriate techniques to prosecute the immune responses which are driving these conditions.  ... More ...  


Risk Grade

Where does OXFD fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 16.90
Open Date:
Feb. 22, 2019
Close Price:
$ 16.87
Close Date:
Feb. 21, 2019

Consensus Recommendation

Analyst Info